NASDAQ:NRC National Research (NRC) Stock Price, News & Analysis $12.08 -0.32 (-2.58%) Closing price 04/7/2025 04:00 PM EasternExtended Trading$12.10 +0.02 (+0.12%) As of 04/7/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About National Research Stock (NASDAQ:NRC) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get National Research alerts:Sign Up Key Stats Today's Range$11.55▼$12.5850-Day Range$11.92▼$17.8752-Week Range$11.38▼$37.75Volume111,283 shsAverage Volume91,402 shsMarket Capitalization$277.19 millionP/E Ratio11.50Dividend Yield3.97%Price TargetN/AConsensus RatingN/A Company OverviewNational Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty. The company also offers marketing solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient experience, employee engagement, health risk assessments, care transition, and improvement tools. Further, the company provides reputation solutions that allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.Read More… Remove Ads National Research Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks45th Percentile Overall ScoreNRC MarketRank™: National Research scored higher than 45% of companies evaluated by MarketBeat, and ranked 204th out of 312 stocks in the business services sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for National Research. Earnings and Valuation1.3 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of National Research is 11.50, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 20.62.Price to Earnings Ratio vs. SectorThe P/E ratio of National Research is 11.50, which means that it is trading at a less expensive P/E ratio than the Business Services sector average P/E ratio of about 27.55.Price to Book Value per Share RatioNational Research has a P/B Ratio of 5.98. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about National Research's valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.93% of the float of National Research has been sold short.Short Interest Ratio / Days to CoverNational Research has a short interest ratio ("days to cover") of 3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in National Research has recently decreased by 9.19%, indicating that investor sentiment is improving significantly. Dividend2.5 / 5Dividend StrengthModerate Dividend LeadershipNational Research is a leading dividend payer. It pays a dividend yield of 3.74%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthNational Research does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of National Research is 45.71%. This payout ratio is at a healthy, sustainable level, below 75%.Read more about National Research's dividend. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted1.93% of the float of National Research has been sold short.Short Interest Ratio / Days to CoverNational Research has a short interest ratio ("days to cover") of 3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in National Research has recently decreased by 9.19%, indicating that investor sentiment is improving significantly. News and Social Media2.1 / 5News SentimentN/A News SentimentNational Research has a news sentiment score of 0.84. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.63 average news sentiment score of Business Services companies. Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, National Research insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 2.00% of the stock of National Research is held by insiders.Percentage Held by Institutions47.26% of the stock of National Research is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about National Research's insider trading history. Receive NRC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for National Research and its competitors with MarketBeat's FREE daily newsletter. Email Address NRC Stock News HeadlinesNational Research Corporation Declares Quarterly DividendMarch 24, 2025 | businesswire.comTop Stock Reports for Philip Morris, Booking Holdings & Anheuser-BuschMarch 21, 2025 | finance.yahoo.comThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR! He says these 5 stocks are trading for less than $2 right now… But they could soon SOAR in Trump’s first 100 days.April 8, 2025 | Timothy Sykes (Ad)National Research Corporation names Trent Green as new CEOMarch 5, 2025 | markets.businessinsider.comInternal memo: Amazon One Medical CEO Trent Green leaving to lead publicly traded NRC HealthMarch 4, 2025 | msn.comNational Research Corporation Appoints Trent Green as Chief Executive OfficerMarch 4, 2025 | finance.yahoo.comNational Research Names Trent Green CEOMarch 4, 2025 | marketwatch.comNIH partially lifts freeze on funding process for medical researchFebruary 27, 2025 | knpr.orgSee More Headlines NRC Stock Analysis - Frequently Asked Questions How have NRC shares performed this year? National Research's stock was trading at $17.64 on January 1st, 2025. Since then, NRC stock has decreased by 31.5% and is now trading at $12.08. View the best growth stocks for 2025 here. How were National Research's earnings last quarter? National Research Co. (NASDAQ:NRC) posted its quarterly earnings data on Monday, January, 27th. The company reported $0.28 EPS for the quarter. National Research had a net margin of 17.32% and a trailing twelve-month return on equity of 66.52%. Does National Research have any subsidiaries? The following companies are subsidiaries of National Research: PatientWisdom Inc., The Governance Institute, and National Research Corporation Canada. Who are National Research's major shareholders? Top institutional investors of National Research include GAMMA Investing LLC (0.07%). Insiders that own company stock include Amandla Mk Trust, Kevin R Karas and Jona S Raasch. View institutional ownership trends. How do I buy shares of National Research? Shares of NRC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of National Research own? Based on aggregate information from My MarketBeat watchlists, some other companies that National Research investors own include Meta Platforms (META), NVIDIA (NVDA), Tesla (TSLA), Alphabet (GOOG), Netflix (NFLX), Advanced Micro Devices (AMD) and JPMorgan Chase & Co. (JPM). Company Calendar Record date for 1/10 Dividend12/27/2024Ex-Dividend for 1/10 Dividend12/27/2024Dividend Payable1/10/2025Last Earnings1/27/2025Record date for 4/11 Dividend3/28/2025Ex-Dividend for 4/11 Dividend3/28/2025Today4/07/2025Dividend Payable4/11/2025Next Earnings (Estimated)5/05/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorBusiness Services Industry Commercial physical research Sub-IndustryBusiness Services Current SymbolNASDAQ:NRC CIK70487 Webwww.nrchealth.com Phone(402) 475-2525Fax402-475-9061Employees490Year Founded1981Profitability EPS (Most Recent Fiscal Year)$1.05 Trailing P/E Ratio11.59 Forward P/E RatioN/A P/E GrowthN/ANet Income$24.78 million Net Margins17.32% Pretax Margin24.48% Return on Equity66.52% Return on Assets20.00% Debt Debt-to-Equity Ratio1.30 Current Ratio0.47 Quick Ratio0.47 Sales & Book Value Annual Sales$143.06 million Price / Sales1.94 Cash Flow$1.12 per share Price / Cash Flow10.81 Book Value$2.02 per share Price / Book5.98Miscellaneous Outstanding Shares22,946,000Free Float23,006,000Market Cap$277.23 million OptionableOptionable Beta0.41 Social Links 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.Get This Free Report This page (NASDAQ:NRC) was last updated on 4/8/2025 by MarketBeat.com Staff From Our PartnersAmazon ShockerJeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | SponsoredFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredElon Musk Demands Fort Knox AuditWith gold prices recently soaring to record highs over $3,000 an ounce, and central banks rushing to accumulat...The Oxford Club | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding National Research Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share National Research With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.